Crossmark

Patient-specific 3D printed and augmented reality kidney and prostate cancer models: impact on patient education

Crossref DOI link: https://doi.org/10.1186/s41205-019-0041-3

Published Online: 2019-02-19

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wake, Nicole http://orcid.org/0000-0002-8441-6059
Rosenkrantz, Andrew B.

Huang, Richard

Park, Katalina U.

Wysock, James S.

Taneja, Samir S.

Huang, William C.

Sodickson, Daniel K.

Chandarana, Hersh
Funding

Funding for this research was provided by:

National Institute of Biomedical Imaging and Bioengineering (NIH P41 EB017183)
License Information

Text and Data Mining valid from 2019-02-19

Version of Record valid from 2019-02-19
More Information

Article History

Received: 28 October 2018

Accepted: 17 January 2019

First Online: 19 February 2019

Ethics approval and consent to participate

: This study was approved by the NYU Langone Health Institutional Review Board (IRB). All patients signed written informed consent to participate.

: All authors provided consent for publication.

: Financial and Non-Financial Disclosures related to this work:NW –In-Kind Research Support: Stratasys, Ltd.Financial and Non-Financial Disclosures not related to this work:ABR – Royalties, Thieme Medical Publishers, Inc.SST – Royalties, Reed Elsevier Consultant, Reed Elsevier.DKS – Royalties, General Electric Company License agreement, General Electric Company; Royalties, Bruker Corporation License agreement, Bruker Corporation; Research collaboration, Siemens AG.HC – Equipment support, Siemens AG; Software support, Siemens AG; Advisory Board, Siemens AG; Speaker, Bayer AG.No competing interests: RH, KUP, JSW.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below